Insider Trading April 17, 2026 04:28 PM

Equitable Holdings COO Disposes of $582,697 in Stock; Exercises Options as Merger Moves Advance

Jeffrey Hurd sold 14,358 shares and exercised options for 9,358 shares amid ongoing merger-related developments and mixed quarterly results

By Hana Yamamoto EQH
Equitable Holdings COO Disposes of $582,697 in Stock; Exercises Options as Merger Moves Advance
EQH

Equitable Holdings Chief Operating Officer Jeffrey J. Hurd sold 14,358 shares of company stock on April 15, 2026, generating roughly $582,697 from multiple trades priced between $40.4399 and $41.0574. On the same day he exercised options for 9,358 shares at $21.34 each. After these transactions Hurd directly holds 84,403.4032 shares, including restricted stock units. The company recently posted fourth-quarter 2025 results with EPS of $1.76 that met expectations but revenue of $3.28 billion that missed forecasts, and continues to advance merger-related agreements involving Nippon Life and Corebridge Financial. Analysts have reacted with upgraded ratings and highlighted strategic merits and risks tied to insurer cash flows and private credit exposure.

Key Points

  • COO Jeffrey J. Hurd sold 14,358 shares on April 15, 2026, for approximately $582,697, with trade prices between $40.4399 and $41.0574.
  • Hurd exercised options to acquire 9,358 shares at $21.34 per share for a total of $199,699 on the same date; he now directly owns 84,403.4032 shares inclusive of restricted stock units.
  • Equitable's Q4 2025 EPS of $1.76 met expectations while revenue of $3.28 billion missed the $3.95 billion forecast; merger-related Voting and Support Agreement involves Nippon Life and Corebridge and has prompted analyst reactions.

Summary

Jeffrey J. Hurd, the Chief Operating Officer of Equitable Holdings, Inc. (NYSE:EQH), carried out a block of stock sales on April 15, 2026, and executed option exercises on the same date. The moves leave him with direct ownership of 84,403.4032 shares, inclusive of restricted stock units. These transactions occur against a backdrop of recent quarterly results and ongoing merger-related arrangements that have prompted analyst commentary.


Insider transactions

On April 15, 2026, Hurd sold a total of 14,358 shares of Equitable Holdings common stock for approximately $582,697. The sales were completed across multiple trades with execution prices spanning from $40.4399 to $41.0574 per share. At the time of reporting the stock was trading at $41.73, which the company notes represents a roughly 12% increase over the preceding week.

In addition to the open-market sales, Hurd exercised stock options on the same day to acquire 9,358 shares at an exercise price of $21.34 per share, representing a total outlay of $199,699 for those optioned shares.


Post-transaction holdings and valuation note

Following the sales and option exercise, Hurd is reported to directly own 84,403.4032 shares of Equitable Holdings, a figure that includes restricted stock units. An InvestingPro analysis cited in the company reporting indicates that the stock appears overvalued relative to its Fair Value.


Recent corporate results and strategic activity

Equitable Holdings reported fourth-quarter 2025 results showing earnings per share of $1.76, matching analyst expectations. Revenue for the period was $3.28 billion, falling short of an expected $3.95 billion and constituting a 16.96% negative surprise versus the forecast.

Separately, Equitable Holdings has entered into a Voting and Support Agreement involving Nippon Life Insurance Company and Corebridge Financial in connection with a previously announced merger. Under the terms disclosed, Nippon Life has committed to vote its shares in favor of the merger at an upcoming Corebridge special stockholder meeting.


Analyst reactions

Raymond James upgraded its view of Equitable Holdings from Market Perform to Strong Buy, citing a favorable outlook for the proposed merger with Corebridge Financial and underscoring the combined entity's distribution strength as well as in-house asset management and product manufacturing capabilities. Barclays analysts also identified Equitable Holdings as an attractive opportunity for investors focused on the life insurance sector, while highlighting the need for detailed assessment of insurers' cash flow projections and private credit exposure.


Context and investor takeaways

The sequence of insider selling, option exercise, mixed quarterly results and the emergence of merger-related commitments and analyst upgrades presents a multifaceted picture for investors. The reported sales and option exercise are factual transactions that alter the insider ownership profile; the company’s earnings met consensus while revenue missed forecasts; and strategic developments tied to the merger continue to draw analyst scrutiny over both potential benefits and risks.

Where information is limited in the public disclosures, the company and its advisors remain the appropriate sources for additional detail on timing, implementation and vote mechanics related to the merger arrangements and any subsequent operational integration plans.


Key points

  • COO Jeffrey J. Hurd sold 14,358 shares on April 15, 2026, for about $582,697 with trade prices between $40.4399 and $41.0574.
  • Hurd exercised options for 9,358 shares at $21.34 per share on the same day, totaling $199,699.
  • Equitable reported Q4 2025 EPS of $1.76 (in line) and revenue of $3.28 billion (below a $3.95 billion forecast), and has a Voting and Support Agreement involving Nippon Life and Corebridge Financial related to a pending merger.

Risks and uncertainties

  • Revenue shortfall risk: The company posted revenue below expectations for Q4 2025, which may affect market perceptions of near-term performance in the insurance sector.
  • Merger execution risk: The Voting and Support Agreement is tied to a previously announced merger; outcomes depend on shareholder voting at the Corebridge special meeting and subsequent integration steps.
  • Valuation uncertainty: An InvestingPro analysis flagged the stock as appearing overvalued relative to its Fair Value, highlighting valuation sensitivity.

Risks

  • Revenue came in below expectations for Q4 2025, which may weigh on investor confidence in the insurance sector.
  • The merger’s success depends on shareholder approval and subsequent execution, creating execution and integration risk for the combined entity.
  • Analyst valuation divergence: InvestingPro indicates the stock appears overvalued relative to Fair Value, introducing valuation risk for investors.

More from Insider Trading

MapLight General Counsel Sells $49K in Stock as Analysts Monitor Upcoming Phase II Readout Apr 17, 2026 MapLight Therapeutics CSO Sells 4,413 Shares for $122,573 Amid Rally Apr 17, 2026 Copart CEO Disposes Nearly $870K in Stock; Exercises Options to Buy More Shares Apr 17, 2026 Schrödinger CFO Disposes of 844 Shares in Automated Plan; Holdings Remain Substantial Apr 17, 2026 MIAX CEO Executes $9.7 Million Stock Sale, Exercises Options Amid Strong Q4 Results Apr 17, 2026